The Quality Digest

January 2023 Edition

January 3, 2023

Clinical News

Updated Diabetes Practice Guidelines

The American Diabetes Association (ADA) has released the “Standards of Care in Diabetes – 2023,” which provides vital new and updated practice guidelines to care for people with diabetes and prediabetes. Read the ADA’s press release here for notable updates and changes.

Read More

Clinical Alerts: Drug Shortages

The U.S. is experiencing shortages of oseltamivir (Tamiflu), albuterol, and oral amoxicillin and amoxicillin clavulanate (Augmentin). Get the details in these Clinical Alerts:

Oseltamivir (Tamiflu)


Oral Amoxicillin/Augmentin

Embed QAPI in the Culture to Combat Staffing Challenges

CMS now requires Quality Assurance and Performance Improvement (QAPI) programs to deal with a full range of facility processes, from resident billing to abuse reporting. This will require a complete culture change that calls for input from everyone. Learn how to build staff involvement and loyalty through QAPI.

Read More

E-Guide: Medication Management – Reducing Risk and Improving Outcomes for Individuals with I/DD

Individuals with I/DD tend to have more comorbidities and take more long-term medications than the general population. Given the risks for polypharmacy and adverse effects, effective medication management is key to achieving healthier outcomes. Learn 3 tips for successful medication management in this population.

Read More

KRAZATI™ Receives FDA Approval for Treatment of Non-Small Cell Lung Cancer

KRAZATI™ (adagrasib) was recently approved by the FDA for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer, as determined by an FDA approved test, who have received at least one prior systemic therapy.

Read More

Amerita Published Study Shows Importance of Home Parenteral Nutrition

A recent study by Amerita, published in BMJ Nutrition, Prevention & Health, shows the importance of home parenteral nutrition (HPN) and a multidisciplinary nutritional support team for patients with intestinal failure requiring long-term nutritional support.

Read More

Regulatory Updates

Drug Pricing Reform in the Inflation Reduction Act

The Inflation Reduction Act, signed by President Biden in August 2022, will have far-reaching effects and important consequences for the nation’s drug pricing system. This article, the first in a 2-part series from the Duke-Margolis Center for Health Policy at Duke University, sums up some of the expected impacts.

Read More

Upcoming Events

All webinar times are 1:00pm ET / 12:00pm CT

Tuesday, January 10: The Four Ds of Narcotics

Tuesday, January 17: Steps to Fall Prevention

Tuesday, January 31: Psychotropic Stewardship: Practical Solutions to Impractical Challenges

Tuesday, February 7: Developing a Strategic Approach for IV Therapy

Tuesday, February 14: PEDs and the Medication Mix in Assisted Living

Tuesday, March 7: Insulin Management